Business & regional news

Month Year

Month Year

Nov 14, 2025

Medtronic Aurora EV-ICD™ system demonstrates exceptional results at six months in the Enlighten real-world post-market study while the OmniaSecure™ defibrillation lead sustains performance at three years in the LEADR Pivotal Trial

APHRS.25: Medtronic showcases breadth of defibrillation portfolio with outcomes from extravascular and transvenous defibrillation studies for the treatment of dangerous heart rhythm episodes
- Cardiac Rhythm Management
Sep 2, 2025

Compelling data at ESC Congress 2025 reinforce safety and performance of the Medtronic OmniaSecure™ defibrillation lead, including in the left bundle branch area

The upcoming U.S. launch of the small-diameter OmniaSecure defibrillation lead will introduce the first FDA-approved lead for both adults and adolescent pediatric patients
- Cardiac Rhythm Management
Feb 6, 2025

DiVERT Stroke study uncovers sex-based disparities in post-stroke cardiac care

Women are less likely than men to receive post-stroke cardiac monitoring according to a new analysis unveiled at the International Stroke Conference 2025
- Cardiac Rhythm Management
Jan 16, 2025

Medtronic LINQ™ family of insertable cardiac monitors with AI-based algorithms accurately predicts risk thresholds for patients with atrial fibrillation

DEFINE AFib results at AF Symposium 2025: First-of-its-kind app-based study uses AF burden data to identify patients at high risk for AF-related healthcare utilization

LINQ™ insertable cardiac monitors showed 4 times greater episode sensitivity compared to Apple Watch™*
- Cardiac Rhythm Management
Sep 2, 2024

Medtronic EV ICD global pivotal trial final results demonstrate high ATP success and effective defibrillation: ESC Congress 2024
- Cardiac Rhythm Management
May 13, 2024

Medtronic celebrates 10 years of Reveal LINQ™ ICM by adding artificial intelligence algorithms

Medtronic has modernized its Reveal LINQ™ Insertable Cardiac Monitor (ICM) with artificial intelligence capabilities to reduce false alerts
- Cardiac Rhythm Management
Feb 7, 2024

Medtronic LINQ Insertable Cardiac Monitors prove cost-effective compared to standard of care in ischemic stroke patients with suspected atrial fibrillation

STROKE AF study shows long-term continuous cardiac monitoring delivers strong economic value driven by fewer projected lifetime strokes
- Cardiac Rhythm Management
Nov 13, 2023

New data demonstrates Medtronic LINQ II insertable cardiac monitors and AccuRhythm AI algorithm further reduce false alerts

AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year
- Cardiac Rhythm Management
Aug 28, 2023

ESC Congress 2023: Real-world analyses highlight benefits of Medtronic ICDs for preventing sudden cardiac death

• Improved survival with ICD therapy: nearly 25% lower risk of death in indicated patients receiving an ICD vs. no ICD
• ICDs confer additional long-term benefits after initial device replacement
- Cardiac Rhythm Management
Jun 20, 2023

Medtronic Statement on FDA Classification of Voluntary Action on Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Defibrillators
- Cardiac Rhythm Management

Show per page